2016 VAM: 1506 - The Safety of Asthma and Allergy Medications During Pregnancy: New Horizons

The purposes of this workshop are to 1) present knowledge gaps regarding the safety of asthma and allergy medications during pregnancy; 2) present the structure and function of the new FDA pregnancy labeling system; and 3) describe the VAMPSS system and show how VAMPSS can fill in knowledge gaps regarding the safety of asthma and allergy medications during pregnancy.

AMA PRA Category 1 Credits™: 1.25
CE: 1.25

Credit must be claimed by May 31, 2018.  Any credit request on or after June 1, 2018 will be subject to an administrative fee.

Target Audience

Physicians
Allergists/Immunologists
Nurses
Nurse Practitioners
Allied Health Professionals

Learning Objectives

Upon completion of this session, participants should be able to:

1.  Identify knowledge gaps regarding the safety of asthma and allergy medications during pregnancy
2.  Optimally use the information provided by the new FDA pregnancy labeling system for clinical decision making
3.  Appreciate the role of VAMPSS in providing new information for the pregnancy label and filling in knowledge gaps regarding the safety of asthma and allergy medications during pregnancy

Additional Information

AttachmentSize
PDF icon 2016 Annual Meeting Disclosures120.13 KB
Summary
Available credit: 
  • 1.25 Attendance
    Attendance credit.
  • 1.25 CE
    CE credit.
  • 1.25 CME
    CME credit.
Course opens: 
05/31/2016
Course expires: 
05/31/2018
Cost:
$15.00
Part of: 
2016 Virtual Annual Meeting Recordings
Rating: 
0

Christina Chambers, PhD MPH, University of California, San Diego, San Diego, CA

Tamara Johnson, MD MS, FDA, Silver Spring, MD

Jennifer A. Namazy, MD FAAAAI, Scripps Clinic Medical Group, San Diego, CA

Available Credit

  • 1.25 Attendance
    Attendance credit.
  • 1.25 CE
    CE credit.
  • 1.25 CME
    CME credit.

Price

Cost:
$15.00
Please login or register to take this course.

Required Hardware/software

Our system supports the two most recent versions of Safari, Google Chrome, and Firefox. Internet Explorer is not recommended.